Fig. 3
From: A single centre experience of patients with rare cancers referred for early phase clinical trials
a OS comparison of EPCTs participants vs fit patients who did not proceed with a trial vs ineligible patients, b OS comparison between patients with good (0–1) and poor (2–3) RMH predictive scores